One Way To Force Down Drug Prices: Have The U.S. Exercise Its Patent Rights
"...Trump already has a weapon he could deploy to cut the prices of at least some expensive medications.
That weapon is called "march-in rights."...
...[L]ower prices could also make drug companies less eager to invest lots of money in new medications.
That's the trade-off the government has always had to wrestle with. But it's one Trump could very well decide is worthwhile.
"Perhaps we as a country would rather have lower drug prices and a little less innovation," [Sara Fisher] Ellison [an economist at MIT] said."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.